Novel splicing factor RBM25 modulates Bcl-x Pre-mRNA 5′ splice site selection

Molecular and Cellular Biology

Volumn 28, Issue 19, 2008, Pages 5924-5936

  Zhou, AnYu ^a,b   Ou, Alexander C ^a   Cho, Aeri ^a   Benz Jr , Edward J ^a,b,c,d,e   Huang, Shu Ching ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER HARVARD CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MESSENGER RNA PRECURSOR; PROTEIN BCL X; RNA; RNA BINDING PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; SPLICING FACTOR RBM25; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING;

ALTERNATIVE SPLICING; APOPTOSIS; BCL-X PROTEIN; CELL LINE; EXONS; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RNA SPLICE SITES; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 52649127884     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00560-08     Document Type: Article

References (57)

1. Bingle, C. D., R. W. Craig, B. M. Swales, V. Singleton, P. Zhou, and M. K. Whyte. 2000. Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death. J. Biol. Chem. 275:22136-22146.
2. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
3. Blencowe, B. J. 2000. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25:106-110.
4. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
5. Bregman, D. B., L. Du, S. van der Zee, and S. L. Warren. 1995. Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains. J. Cell Biol. 129:287-298.
6. Cazalla, D., K. Newton, and J. F. Caceres. 2005. A novel SR-related protein is required for the second step of pre-mRNA splicing. Mol. Cell. Biol. 25:2969-2980.
7. Cazalla, D., J. Zhu, L. Manche, E. Huber, A. R. Krainer, and J. F. Caceres. 2002. Nuclear export and retention signals in the RS domain of SR proteins. Mol. Cell. Biol. 22:6871-6882.
8. Chalfant, C. E., K. Rathman, R. L. Pinkerman, R. E. Wood, L. M. Obeid, B. Ogretmen, and Y. A. Hannun. 2002. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277:12587-12595.
9. Chen, Y. I., R. E. Moore, H. Y. Ge, M. K. Young, T. D. Lee, and S. W. Stevens. 2007. Proteomic analysis of in vivo-assembled pre-mRNA splicing complexes expands the catalog of participating factors. Nucleic Acids Res. 35:3928-3944.
10. Del Gatto-Konczak, F., C. F. Bourgeois, C. Le Guiner, L. Kister, M. C. Gesnel, J. Stevenin, and R. Breathnach. 2000. The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Mol. Cell. Biol. 20:6287-6299.
11. Del Gatto-Konezak, F., M. Olive, M. C. Gesnel, and R. Breathnach. 1999. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol. Cell. Biol. 19:251-260.
12. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
13. Förch, P., O. Puig, N. Kedersha, C. Martinez, S. Granneman, B. Seraphin, P. Anderson, and J. Valcarcel. 2000. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell 6:1089-1098.
14. Förch, P., O. Puig, C. Martinez, B. Seraphin, and J. Valcarcel. 2002. The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. EMBO J. 21:6882-6892.
15. Fortes, P., D. Bilbao-Cortes, M. Fornerod, G. Rigaut, W. Raymond, B. Seraphin, and I. W. Mattaj. 1999. Luc7p, a novel yeast U1 snRNP protein with a role in 5′ splice site recognition. Genes Dev. 13:2425-2438.
16. Fortes, P., D. Longman, S. McCracken, J. Y. Ip, R. Poot, I. W. Mattaj, J. F. Caceres, and B. J. Blencowe. 2007. Identification and characterization of RED120: a conserved PWI domain protein with links to splicing and 3′-end formation. FEBS Lett. 581:3087-3097.
17. Garneau, D., T. Revil, J. F. Fisette, and B. Chabot. 2005. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 280:22641-22650.
18. Graveley, B. R., and T. Maniatis. 1998. Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol. Cell 1:765-771.
19. fyn. Mol. Biol. Cell 10:3909-3926.
20. Hiller, M., Z. Zhang, R. Backofen, and S. Stamm. 2007. Pre-mRNA secondary structures influence exon recognition. PLoS Genet. 3:c204.
21. Horowitz, D. S., and A. R. Krainer. 1994. Mechanisms for selecting 5′ splice sites in mammalian pre-mRNA splicing. Trends Genet. 10:100-106.
22. Huang, Y., N. H. Shin, Y. Sun, and K. K. Wang. 2001. Molecular cloning and characterization of a novel caspase-3 variant that attenuates apoptosis induced by proteasome inhibition. Biochem. Biophys. Res. Commun. 283:762-769.
23. Jurica, M. S., and M. J. Moore. 2003. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 12:5-14.
24. Kang, J., M. S. Lee, S. J. Watowich, and D. G. Gorenstein. 2006. Chemiluminescence-based electrophoretic mobility shift assay of RNA-protein interactions: application to binding of viral capsid proteins to RNA. J. Virol. Methods 131:155-159.
25. Lopez, A. J. 1998. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32:279-305.
26. Maniatis, T., and B. Tasic. 2002. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418:236-243.
27. Maris, C., C. Dominguez, and F. H. Allain. 2005. The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J. 272:2118-2131.
28. Massiello, A., J. R. Roesser, and C. E. Chalfant. 2006. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5′ splice site selection of Bcl-x pre-mRNA. FASEB J. 20:1680-1682.
29. Matlin, A. J., F. Clark, and C. W. Smith. 2005. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6:386-398.
30. Misteli, T., J. F. Caceres, and D. L. Spector. 1997. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387:523-527.
31. Nilsen, T. W. 2002. The spliceosome: no assembly required? Mol. Cell 9:8-9.
32. Niranjanakumari, S., E. Lasda, R. Brazas, and M. A. Garcia-Blanco. 2002. Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26:182-190.
33. Norton, P. A. 1994. Alternative pre-mRNA splicing: factors involved in splice site selection. J. Cell Sci. 107:1-7.
34. O'Keefe, R. T., A. Mayeda, C. L. Sadowski, A. R. Krainer, and D. L. Spector. 1994. Disruption of pre-mRNA splicing in vivo results in reorganization of splicing factors. J. Cell Biol. 124:249-260.
35. Paronetto, M. P., T. Achsel, A. Massiello, C. E. Chalfant, and C. Sette. 2007. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J. Cell Biol. 176:929-939.
36. Puig, O., E. Bragado-Nilsson, T. Koski, and B. Seraphin. 2007. The U1 snRNP-associated factor Luc7p affects 5′ splice site selection in yeast and human. Nucleic Acids Res. 35:5874-5885.
37. Revil, T., J. Toutant, L. Shkreta, D. Garneau, P. Cloutier, and B. Chabot. 2007. Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol. 27:8431-8441.
38. Rinke, J., B. Appel, H. Blocker, R. Frank, and R. Luhrmann. 1984. The 5′-terminal sequence of U1 RNA complementary to the consensus 5′ splice site of hnRNA is single-stranded in intact U1 snRNP particles. Nucleic Acids Res. 12:4111-4126.
39. Ryan, K. J., B. N. Charlet, and T. A. Cooper. 2000. Binding of PurH to a muscle-specific splicing enhancer functionally correlates with exon inclusion in vivo. J. Biol. Chem. 275:20618-20626.
40. Sakashita, E., S. Tatsumi, D. Werner, H. Endo, and A. Mayeda. 2004. Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo. Mol. Cell. Biol. 24:1174-1187.
41. Sanford, J. R., J. Ellis, and J. F. Caceres. 2005. Multiple roles of arginine/serine-rich splicing factors in RNA processing. Biochem. Soc. Trans. 33:443-446.
42. Schwerk, C., and K. Schulze-Osthoff. 2005. Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19:1-13.
43. Selvakumar, M., and D. M. Helfman. 1999. Exonic splicing enhancers contribute to the use of both 3′ and 5′ splice site usage of rat beta-tropomyosin pre-mRNA. RNA 5:378-394.
44. Sergeant, K. A., C. F. Bourgeois, C. Dalgliesh, J. P. Venables, J. Stevenin, and D. J. Elliott. 2007. Alternative RNA splicing complexes containing the scaffold attachment factor SAFB2. J. Cell Sci. 120:309-319.
45. Shapiro, M. B., and P. Senapathy. 1986. Automated preparation of DNA sequences for publication. Nucleic Acids Res. 14:65-73.
46. Singh, R., and J. Valcarcel. 2005. Building specificity with nonspecific RNA-binding proteins. Nat. Struct. Mol. Biol. 12:645-653.
47. Smith, C. W., and J. Valcarcel. 2000. Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25:381-388.
48. Spector, D. L., W. H. Schrier, and H. Busch. 1983. Immunoelectron microscopic localization of snRNPs. Biol. Cell 49:1-10.
49. Stetefeld, J., and M. A. Ruegg. 2005. Structural and functional diversity generated by alternative mRNA splicing. Trends Biochem. Sci. 30:515-521.
50. Sutherland, L. C., N. D. Rintala-Maki, R. D. White, and C. D. Morin. 2005. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? J. Cell. Biochem. 94:5-24.
51. Taylor, J. K., Q. Q. Zhang, J. R. Wyatt, and N. M. Dean. 1999. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 17:1097-1100.
52. Xerri, L., P. Parc, P. Brousset, D. Schlaifer, J. Hassoun, J. C. Reed, S. Krajewski, and D. Birnbaum, 1996. Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas. Br. J. Haematol. 92:900-906.
53. Yang, G., S. C. Huang, J. Y. Wu, and E. J. Benz, Jr. 2005. An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood 105:2146-2153.
54. Yang, G., S. C. Huang, J. Y. Wu, and E. J. Benz, Jr. 2008. Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation. Blood 111:392-401.
55. Zhou, H. L., A. P. Baraniak, and H. Lou. 2007. Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing. Mol. Cell. Biol. 27:830-841.
56. Zhu, H., R. A. Hasman, K. M. Young, N. L. Kedersha, and H. Lou. 2003. U1 snRNP-dependent function of TlAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Mol. Cell. Biol. 23:5959-5971.
57. Zhu, J., A. Mayeda, and A. R. Krainer. 2001. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell 8:1351-1361.